A new study suggests that the effectiveness of widely used GLP-1 weight-loss drugs may depend strongly on consistent use. Intermittently stopping and restarting popular GLP-1 weight loss drugs such as Ozempic and Wegovy may weaken their impact over time, according to new research from the Perelman School of Medicine at the University of Pennsylvania. In [...]from SciTechDaily https://ift.tt/kImGSYl
